Table 1.
Donor sample population demographics and SARS-CoV-2 antibody detection.
Study Variable | Total | Donors with SARS-CoV-2 antibody detected | Crude seroprevalence(% [95%CI]) | Adjusted seroprevalence*(% [95%CI]) | p-value | ||
---|---|---|---|---|---|---|---|
Donor population | 8509 | 187 | 2.20% [1.89 – 2.54] | 2.41% [2.09 – 2.76] | |||
Month | February | 1047 | 2 | 0.19% [0.02 – 0.69] | |||
March | 1033 | 3 | 0.29% [0.06 – 0.85] | ||||
April | 1342 | 39 | 2.91% [2.07 – 3.97] | <0.0001 | |||
May | 1277 | 37 | 2.90% [2.04 – 3.99] | ||||
June | 1365 | 37 | 2.71% [1.91 – 3.74] | ||||
July | 1116 | 29 | 2.60% [1.74 – 3.73] | ||||
August | 663 | 23 | 3.47% [2.20 – 5.21] | ||||
September | 666 | 17 | 2.55% [1.49 – 4.09] | ||||
Gender | Male | 4842 | 104 | 2.15% [1.76 – 2.60] | 1.86% [1.50 – 2.29] | ||
Female | 3667 | 83 | 2.26% [1.80 – 2.81] | 2.43% [1.97 – 2.96] | |||
Age (yrs) | 18–29 | 1133 | 46 | 4.06% [2.97 – 5.42] | 5.30% [4.04 – 6.82] | <0.0001 | |
30–39 | 1664 | 46 | 2.76% [2.02 – 3.69] | 3.55% [2.70 – 4.57] | <0.0001 | ||
40–49 | 2271 | 39 | 1.72% [1.22 – 2.35] | 1.50% [1.04 – 2.09] | |||
50–59 | 2241 | 37 | 1.65% [1.16 – 2.28] | 1.21% [0.79 – 1.75] | |||
≥60 | 1200 | 19 | 1.58% [0.95 – 2.47] | 1.67% [1.02 – 2.57] | |||
Province | Leinster | 4955 | 136 | 2.74% [2.30 – 3.25] | 2.95% [2.48 – 3.47] | <0.0001 | |
Munster | 2257 | 37 | 1.64% [1.15 – 2.26] | 1.86% [1.34 – 2.52] | |||
Ulster | 648 | 9 | 1.39% [0.64 – 2.64] | 1.39% [0.63 – 2.63] | |||
Connacht | 649 | 5 | 0.77% [0.25 – 1.80] | 1.23% [0.53 – 2.43] | |||
Blood Grouping | ABO | A | 2367 | 67 | 2.83% [2.19 – 3.58] | ||
B | 964 | 17 | 1.76% [1.03 – 2.82] | ||||
AB | 203 | 6 | 2.96% [1.09 – 6.43] | ||||
O | 4975 | 97 | 1.95% [1.58 – 2.38] | ||||
A antigen | + | 2570 | 73 | 2.84% [2.22 – 3.57] | <0.0001 | ||
− | 5939 | 114 | 1.92% [1.58 – 2.31] | ||||
RhD | + | 6248 | 139 | 2.22% [1.87 – 2.63] | |||
− | 2261 | 48 | 2.12% [1.57 – 2.82] |
Adjusted to National demographic distributions recorded in the 2016 CENSUS www.CSO.ie.